sorafenib has been researched along with schisanhenol b in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (schisanhenol b) | Trials (schisanhenol b) | Recent Studies (post-2010) (schisanhenol b) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 5 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, B; Cao, Y; Hu, K; Li, F; Li, R; Li, Y; Ma, X; Peng, H; Peng, T; Sheng, Y; Sun, H; Wang, F; Wang, M; Xi, R; Xiao, W; Zhang, G; Zhang, H; Zhou, Z | 1 |
1 other study(ies) available for sorafenib and schisanhenol b
| Article | Year |
|---|---|
Identification of a Novel TAR RNA-Binding Protein 2 Modulator with Potential Therapeutic Activity against Hepatocellular Carcinoma.
Topics: Animals; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; DEAD-box RNA Helicases; Enoxacin; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Polycyclic Compounds; Proteome; Ribonuclease III; RNA-Binding Proteins; Structure-Activity Relationship; Transcriptome; Transplantation, Heterologous | 2021 |